发明名称 A2M FRAGMENTS AND APPLICATIONS THEREOF
摘要 The application relates to a polypeptide, the amino acid sequence of which is the sequence of a sub-fragment of the C-terminal thioester-cleaved fragment of human alpha-2-macroglobulin (A2M), wherein the molecular weight of said polypeptide is of 36 to 44 kDa, and wherein the first N-terminal amino acid of said polypeptide is an amino acid, which, in the full length sequence of said human A2M, is at a position 1,098 or 1,085 or 1,084 or 1,083, and the last C-terminal amino acid of said polypeptide is an amino acid, which, in the full length sequence of said human A2M, is one of the last twenty C-terminal amino acids. This polypeptide is differently abundant depending on the stage of liver fibrosis. The application also relates to means deriving therefrom and to the application thereof, notably in the field of hepatitis.
申请公布号 US2014223588(A1) 申请公布日期 2014.08.07
申请号 US201114234503 申请日期 2011.07.27
申请人 Batxelli Isabelle Catherine;Watelet Bénédicte 发明人 Batxelli Isabelle Catherine;Watelet Bénédicte
分类号 C07K14/47;C07K16/18;C07K7/08;C07K7/06 主分类号 C07K14/47
代理机构 代理人
主权项 1. A polypeptide, the amino acid sequence of which is the sequence of a sub-fragment of the C-terminal thioester-cleaved fragment of human alpha-2-macroglobulin (A2M), wherein the molecular weight of said polypeptide is of 36 to 44 kDa, and wherein: the first N-terminal amino acid of said polypeptide is an amino acid, which, in the full length sequence of said human A2M, is at a position 1,098 or 1,085 or 1,084 or 1,083, and the last C-terminal amino acid of said polypeptide is an amino acid, which, in the full length sequence of said human A2M, is one of the last twenty C-terminal amino acids.
地址 Aigues-Vives FR